compound is bound to specific receptor sites in 1. Infusion of sufficient renin to raise the blood pressure of normal rats to hypertensive levels resulted in increased renin in the arterial wall.
Introduction
The role of the renin-angiotensin system in blood pressure maintenance is still unsettled. Studies with radioactive angiotensin I1 indicate that this Correspondence: Dr Josephine B. Garst, 409 South Orange Grove Avenue, Los Angeles, California 90036, U.S.A. vascular smooth muscle (Baudoin, Meyer & Worcel, 197 1) . This suggests that renin, through angiotensin, has a specific function in this tissue. But in chronic renal hypertension and in spontaneous hypertension in rats (Okamot+Aoki strain) the relationship of renin to elevated blood pressure has been questioned because of the observation that circulating renin is normal or low (Koletsky, Rivera-Velez, Marsh & Pritchard, 1967; Sokabe, 1966; Koletsky, Shook & RiveraVelez, 1970; Sen, Smeby & Bumpus, 1972; Vincent, Dupont & Sassard, 1976) . On the other hand, others (de Jong, Lovenberg & Sjoerdsma, 1972) have reported that renin increases with age in spontaneously hypertensive rats.
Renin is known to be present in the blood vessel wall of pigs and rats (Dengler, 1956; Gould, Skeggs & Kahn, 1964; Rosenthal, Boucher, RojoOrtega & Genest, 1969) and thus might play a role in blood pressure maintenance. Injection of antirenin into dogs with either acute renin-induced hypertension or chronic one-kidney Goldblatt renal hypertension caused a rapid, partial drop in blood pressure during the first 20 min after infusion in the first model and a much slower drop (4-10 days) in the second. The rate of production of the hypotensive effect is consistent with the hypothesis that neutralization of circulating renin occurred in the acutely hypertensive animals and of vascular wall renin in the chronically hypertensive ones (Hill, Chester & Wisenbaugh, 1970) .
In the rat, the action of an angiotensin I1 antagonist which can penetrate the arterial wall and an angiotensin I1 antiserum which cannot suggested that renin generates angiotensin at a local vascular level in a site not readily accessible to antiserum (Thurston & Swales, 1974) . Additional support for this theory is that converting enzyme inhibitor causes a fall in blood pressure for several hours after bilateral nephrectomy, indicating that the renin-angiotensin system maintains blood pressure in this model even after plasma renin has fallen to insignificant levels (Thurston & Swales, 1977) . In addition, pressor action of renin is present in nephrectomized animals without detectable circulating renin (Schaechtelin, Regoli & Gross, 1964) . Thus it would appear that the amount of circulating renin may not reflect the activity of this substance at its major site of action, namely, the arterial wall.
In the present study we have tested the hypothesis that significant amounts of renin are present in the arterial wall of rats with renininduced hypertension, chronic renal hypertension or spontaneous hypertension.
Methods

Infusion experiments
Normal adult male albino rats were anaesthetized with sodium amylobarbitone, and were vagotomized and heparinized. Both jugular veins were cannulated, the right to obtain blood samples and the left to connect to the infusion pump. Pentolinium tartrate was given as a ganglionic blocking agent. Carotid arterial pressure was continuously monitored. A total of 1.1 Goldblatt units of rat renin in 0-408 ml of sodium chloride solution (155 mmol/l:saline) was infused at the rate of 0.0136 ml/min for 30 min into each of 20 rats. Preliminary trials had shown that this could produce a peak blood pressure similar to that of rats with acute renal hypertension. Twenty-one control rats were infused with 0.408 ml of saline at the same rate and for the same length of time. Four other rats were subjected to the same surgery and connected in the same way to the infusion pump without any infusion.
Approximately 0.5 ml of blood was collected immediately before the start of the infusion, and after 30 min infusion and at 30 min after the end of the infusion. The collected blood was promptly centrifuged in the cold. The plasma was removed and frozen until assayed for angiotensin. Immediately after the third sample was taken the rat was killed with sodium amylobarbitone and the aorta was removed with as many branches as could be obtained. Extraneous fat and connective tissue were quickly removed, the artery was slit lengthwise and washed by dipping once in each of four lots of cold saline with intervening blotting, and quickly weighed and frozen. The homogenized tissue was prepared by the method of Rosenthal et al. (1969) .
The amount of blood that still might be adhering to the arterial wall samples was estimated in six rats to evaluate the magnitude of contamination with plasma renin. The method used depended on the spectral absorbance of haemoglobin at the 4 15 nm peak. The rat's own blood was used to construct a standard absorbance curve to be used to determine the volume of blood in the supernatant of the homogenized tissue. From this volume and the concentration of renin in the rat's own plasma, the amount of contamination with plasma renin, if any, could be calculated.
Such an adjustment is an overcorrection since the peak at 415 nm was due in part, if not largely, to non-haemoglobin material. The absorbance curve of the supernatant of the arterial homogenate was highest in the near-ultraviolet and declined gradually without showing a peak at 415 nm. Despite this, the aforementioned correction was applied to all values obtained for renin concentration in the arterial wall.
Hypertensive rats
Three groups of adult male albino rats were used: normal Wistar (Charles River); spontaneously hypertensive (SH) rats of the OkamotoAoki strain (Kyoto-Wistar derived) from National Institutes of Health, Bethesda, Maryland, U.S.A.; Wistar rats with acute ( A N ) or chronic (CRH) experimental renovascular hypertension (twokidney Goldblatt). Renovascular hypertension was produced by unilateral renal artery constriction as described by Koletsky' et al. (1967) . The right kidney was untouched. After obtaining the blood samples (Koletsky et al., 1967) , the animals were killed and the entire aorta and attached major branches was removed and prepared as described above. The plasma obtained was frozen until used. The samples of blood from the ARH rats were taken from 1 to 6 days after induction of high blood pressure and those from the CRH rats when the blood pressure had remained elevated from 1 to 6 months. Blood and arterial wall samples also were obtained in a similar manner from the SH rats. Environmental conditions were maintained constant throughout.
The normal and the SH rats were divided into groups according to mean age: normal rats, younger, 3.5 months, and older, 9.5 months; SH rats, younger, 6.5 months, and older, 12.0 months. All renal hypertensive rats were young (5.1 months). The young normal rats served as controls for all of the young hypertensive animals.
Assay methods
Assay of renin in a sample was done by measurement of the angiotensin produced by the action of renin on renin substrate. The renin activity of a sample depends on the amount of endogenous substrate present. Since the latter may be insufficient for the amount of renin present, determination of renin concentration in a sample requires the addition of substrate. Rat renin substrate (Boucher, Menard & Genest, 1967) was prepared from rats given a solution of 5% glucose and 1% sodium chloride solution instead of water to drink 48 h before nephrectomy. The substrate preparation was tested for endogenous renin activity by incubation and assay with no added renin. The concentration of substrate in the preparation in terms of the angiotensin I1 produced by the substrate preparation was assayed with standardized rat renin.
Renin concentration was determined by the methods of incubation and chromatography of Boucher et pl. (1967) in plasma samples obtained in the infusion experiments and from the older SH rats and their normotensive controls, and also in all homogenized arterial wall samples. The following changes were made in the incubation. Only four samples were prepared at a time and they were not filtered. Either the entire arterial homogenate or 0.1 ml of plasma was incubated with prepared substrate (PH 6.5) for 16 h at 37OC in a gyrotory water bath (New Brunswick Scientific Co., New Brunswick, N.J., U.S.A.). Chromatography of the incubation mixture was done with no changes on Dowex resin 50W-X2 (NH,+) (Dow Chemical Co., Midland, Michigan, U.S.A.) in a glass column.
The angiotensin I obtained by the above methods was assayed (Skeggs, Kahn & Marsh, 1953 ) in a rat prepared as for the infusion experiments except that only one jugular vein was cannulated. This was used for the injection of the assay material or standard. Carotid arterial pressure was recorded directly. The volume of sample or standard plus any necessary diluent (Skeggs et al., 1953) was 0.25 ml per injection. Angiotensin I1 standard (research standard A/65, courtesy of the Medical Research Council, National Institute for Medical Research, Mill Hill, London, U.K.) was used to bracket aliquots of the samples assayed. The sensitivity of the bioassay allowed at least three, or more usually six to eight, aliquots of a sample to be assayed. The lower limit of sensitivity for the average test rat is 0.47 pmol of angiotensin 11.
The samples of blood or tissue for analysis were not large enough to permit the use of aliquots for non-incubated control systems. The information sought was whether or not there was a significantly greater amount of renin in the blood or arterial wall of the hypertensive rats than in the normotensive control animals under the same conditions. The addition of ethylenediamine tetra-acetate ensures that the angiotensin I formed during the incubation will not be converted into any other angiotensin. The rapid pressor response when the angiotensin sample is injected is due to the instantaneous conversion of angiotensin I into angiotensin 11. The results would not be affected by any angiotensin I11 formed in the test rat since its formation is slower than that of angiotensin 11.
Renin activity in the plasma samples from the younger hypertensive rats and their control rats was determined as angiotensin I by a double-antibody radioimmunoassay with '251-labelled angiotensin I (Clinical Assays, Cambridge, Mass., U.S.A.). The radioactivity was counted without transfer from the assay tubes in a solid crystal well counter (Picker). The highly specific antiserum bound less than 1% of renin substrate and less than 0.1% of angiotensin 11. The limit of sensitivity was approximately 0.10 pmol. The radioimmunoassay could not be used for measurement of angiotensin in the arterial wall as a method in which exogenous substrate is not added does not produce enough angiotensin to be measured by this procedure.
The Mann-Whitney U test (Siegel, 1956 ) was used to determine the significance of the differences found because of the abnormally distributed data obtained in the study.
Results
Normotensive rats infused with renin plus saline had a significantly greater (P = 0.008) concentration of arterial wall renin than did normotensive rats infused with saline only (Fig. 1) . The mean rise in blood pressure for the renin-infused rats was 85 mmHg compared with 10 mmHg for the salineinfused rats. The older SH rats showed a significant rise ( P < 0.05) in the concentration of renin in the arterial wall, a highly significant fall (P < 0.001) in plasma renin in the renal vein and a small, but significant (P < 0.05), fall in plasma renin in the femoral artery compared with normal rats (Fig. 2 and Fig. 3) . On the other hand, the younger SH rats had normal amounts of renin in the arterial wall (P > 0.05) and in the plasma of both the renal vein and the femoral artery ( P > 0.05) (Fig. 2 and Fig. 4) . The acute renal hypertensive (ARH) rats showed a significant rise ( P < 0.01) in the renin in the arterial wall and in the plasma renin in the femoral artery (P < 0-Ol), and a rise of lesser significance ( P < 0.05) in the plasma renin in the renal vein ( Fig. 2 and Fig. 4 ) compared with normal rats. But, although the chronic renal hypertensive (CRH) rats had normal or low plasma renin in the renal vein and femoral artery ( P > 0.05), they had significantly elevated arterial wall renin ( P < 0.01) (Fig. 2 and Fig. 4) . 
-
Discussion
The concentration of circulating renin does not necessarily represent the effective concentration at the site of action, i.e. the arterial wall. We have demonstrated that renin infused into the normotensive rat h a quantity large enough to produce hypertension can at the same time raise the concentration of renin in the arterial wall. We also have shown that experimental renal hypertension in the rat is accompanied in the acute stage not only by elevated plasma renin activity, but also by an elevated concentration of renin in the arterial wall. Furthermore, our results show that as the hypertension becomes chronic, the concentration of renin in the arterial wall remains elevated as the plasma renin activity is reduced to normal or below. Thus, increased arterial wall renin is associated with elevated blood pressure in the acute stage of renal hypertension, and increased renin content may well continue to maintain hypertension in the chronic stage despite the fall in plasma renin at this stage. Although our results for the young rats with spontaneous hypertension show no abnormal amount of renin in the circulation or in the arterial wall, the results for the older rats show that as the rats age circulating renin is depressed and arterial wall renin is elevated. The pattern of change resembles that in chronic renal hypertension. It was reported by Sweet, Columbo & Gaul (1976) that an intracerebroventricular injection of SariIles-angiotensin 11, an antagonist of angiotensin 11, into SH rats lowered the mean arterial pressure in mature rats, but not in young rats.
It is well documented that benign experimental renal hypertension in both the rat and the dog can be divided into two phases: acute and chronic. There is general agreement that andotensin is involved in the production of elevated blood pressure in the acute phase, but there has been considerable doubt expressed that it can be responsible for the elevated pressure in the chronic phase (Koletsky et al., 1967; Blair-West, Coghlan, Denton, Orchard, Scoggins & Wright, 1968; Pals, Masucci, Denning, Sipos & Fessler, 1971; Page, 1974; Hutchinson, Matthews, Dax & Johnston, 1975; Lohmeier & Davies, 1976; Masaki, Ferrario, Bumpus, Bravo & Khosla, 1977) .
The inability of various workers to reduce elevated blood pressure in experimental chronic renal hypertension by the use of agents which block the renin-angiotensin system may lie in the length of the interval of observation after the administration of the blocking agent (cf. Pals et al., Hill et al., 1970) . Or it may be that a longer period of administration of the blocking agent is required. Riegger, Lever, Millar, Morton & Slack (1978) recently reported that prolonged infusion of either saralasin or converting enzyme inhibitor gradually corrects renal hypertension.
Our results show clearly that in acute twokidney Goldblatt renal hypertension elevated circulating renin is accompanied by an increased concentration of renin in the arterial wall. They also show that in the chronic phase of this model circulating renin is depressed, whereas arterial wall renin is augmented as it is in the acute phase. Thus these results suggest a role of the renin-angiotensin system in the maintenance of chronic renal hypertension and possibly in spontaneous hypertension of long duration in older rats.
